Considering the important role of MTX2 in cardiac oxidative phosphorylation (OXPHOS) and glycolysis, these results provide proof of concept that targeting MTX2 might mitigate myocardial I/R injury and other cardiac diseases characterized by metabolic defects. This evidence concerns the gene MTX2 and heart disorder.